STAT September 30, 2024
Allison DeAngelis

The firm is among a select number of biotech VCs to raise new pools of capital this year

DCVC Bio, a Silicon Valley area investment firm launched six years ago by a group of tech, bio,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Investments, Pharma / Biotech, Technology, Trends
J&J drops 340B rebate plan following government pressure
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss Drugs
The top biopharma conferences in 2025
AI algorithm could aid drug discovery, say researchers

Share This Article